0 results available. Select is focused ,type to refine list, press Down to open the menu,
Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The compan...
The following section summarizes insights on Inozyme Pharma Inc's Avg Price / LTM FCF (5y):
We've identified the following companies as similar to Inozyme Pharma Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Avg Price / LTM FCF (5y) in the valuation category include:
Five-year quarterly average P/FCF ratio.
The chart above depicts the distribution of avg price / ltm fcf (5y) for companies operating in the Healthcare sector in the Developed economic region. Over 2,460 companies were considered in this analysis, and 2,369 had meaningful values. The average avg price / ltm fcf (5y) of companies in the sector is -3.3x with a standard deviation of 33.8x.
Inozyme Pharma Inc's Avg Price / LTM FCF (5y) of -5.6x ranks in the 43.5% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,467 |
| Included Constituents | 2,369 |
| Min | -216.4x |
| Max | 149.0x |
| Median | -4.3x |
| Mean | -3.3x |
| Standard Deviation | 33.8x |
You can find companies with similar avg price / ltm fcf (5y) using this stock screener.